85.984.46% ( -4.01 )
Delay Trading: Oct 29, 13:23:16Current ValuationThe current P/E ratio is 43.32, above the reasonable range, cheaper than 10.05% of the time in the past 5 years, and the industry ranks 21/84, the industry Median 19.01.
43.32xP/E
¥89.99Stock price
¥2.08Earnings per share
43.32xP/E
Stock price¥89.99Earnings per share¥2.08
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -41.02x
- Typical range
- -159.48x–-17.55x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 19.01x
023466992
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 19.01x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
688266SHZelgen | 43.32x | 398.39% | ¥23.82B |
002675SZDongcheng Biochem | 50.55x | 51.77% | ¥10.62B |
000403SZPLBIO | 42.29x | 94.32% | ¥8.98B |
000534SZWEDGE CORPORATION | 51.12x | 44.07% | ¥8.74B |
300639SZHybribio Biotech | 58.28x | -- | ¥3.89B |
603739SHVland Biotech | 42.06x | 25.00% | ¥2.98B |
300653SZZHBIO | 40.11x | 20.65% | ¥2.56B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
